File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Bortezomib/bendamustine/dexamethasone induced good partial response in refractory relapse post-ASCT with constitutive RAS activation due to V600E BRAF mutation

TitleBortezomib/bendamustine/dexamethasone induced good partial response in refractory relapse post-ASCT with constitutive RAS activation due to V600E BRAF mutation
Authors
Issue Date2014
Citation
Bone Marrow Transplantation, 2014, v. 49 n. 12, p. 1545-1547 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/199173

 

DC FieldValueLanguage
dc.contributor.authorChim, JCSen_US
dc.contributor.authorWong, KYen_US
dc.date.accessioned2014-07-22T01:05:01Z-
dc.date.available2014-07-22T01:05:01Z-
dc.date.issued2014-
dc.identifier.citationBone Marrow Transplantation, 2014, v. 49 n. 12, p. 1545-1547en_US
dc.identifier.urihttp://hdl.handle.net/10722/199173-
dc.languageengen_US
dc.relation.ispartofBone Marrow Transplantationen_US
dc.titleBortezomib/bendamustine/dexamethasone induced good partial response in refractory relapse post-ASCT with constitutive RAS activation due to V600E BRAF mutationen_US
dc.typeArticleen_US
dc.identifier.emailChim, JCS: jcschim@hku.hken_US
dc.identifier.emailWong, KY: kwanumu@hku.hken_US
dc.identifier.authorityChim, JCS=rp00408en_US
dc.identifier.doi10.1038/bmt.2014.192-
dc.identifier.hkuros231522en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats